Pulmonary Embolism

Clinical Trial Finder

Many patients with pulmonary embolism are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Outpatient Treatment of PE and DVT in the Emergency Department

Conditions:   Pulmonary Embolism;   Deep Vein Thrombosis
Intervention:   Other: Telephone follow-up
Sponsor:   Massachusetts General Hospital
Not yet recruiting - verified August 2015

Evaluation of Soluble Fibrin in Thrombosis Exclusion

Conditions:   Pulmonary Embolism (PE);   Deep Vein Thrombosis (DVT)
Intervention:   Other: Soluble Fibrin
Sponsors:   Diagnostica Stago R&D;   Hôpital Louis Mourier;   Hopital Lariboisière
Not yet recruiting - verified August 2015

Evaluation of Rapid Emergency Echography for Acute Dyspnoea

Condition:   Acute Dyspnea
Intervention:   Device: Echocardiography according to the READ method.
Sponsors:   Centre Hospitalier Universitaire de Besancon;   Centre Hospitalier Germon et Gauthier;   University Hospital, Clermont-Ferrand;   Centre Hospitalier de PAU;   Centre Hospitalier Universitaire de Strasbourg;   Centre Hospitalier Général de Toulon
Not yet recruiting - verified August 2015

Assessment of Radiolabeled rhAnnexin V-128 in Infective Endocarditis

Conditions:   Endocarditis;   Thrombosis
Intervention:   Other: 99mTc-Annexin V-128 SPECT
Sponsors:   Institut National de la Santé Et de la Recherche Médicale, France;   Advanced Accelerator Applications
Not yet recruiting - verified May 2015

Diuretic Vascular Filling in the Initial Management of Acute PE With Right Ventricular Dysfunction Normotensive

Condition:   Pulmonary Embolism
Interventions:   Drug: Furosemide;   Drug: NaCl 9% isotonic
Sponsor:   Centre Hospitalier Universitaire de Nice
Not yet recruiting - verified August 2015

Safety and Efficacy Study of Apixaban to Prevent Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With PEG Asparaginase

Conditions:   Lymphoma;   Acute Lymphoblastic Leukemia
Interventions:   Drug: Apixaban;   Other: No systemic anticoagulant prophylaxis
Sponsor:   Bristol-Myers Squibb
Recruiting - verified August 2015

Outpatient Treatment of Low-risk Pulmonary Embolism

Condition:   Pulmonary Embolism
Intervention:   Other: Outpatient Treatment of Pulmonary Embolism
Sponsor:   Intermountain Health Care, Inc.
Recruiting - verified August 2015

Pulmonary Embolism Diagnosis: Ultrasound Wells Score vs Traditional Wells Score

Condition:   Pulmonary Embolism
Intervention:  
Sponsor:   Azienda Ospedaliero-Universitaria Careggi
Completed - verified August 2015

Sequential Expansion of Comparative Effectiveness of Anticoagulants

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified August 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Warfarin
Sponsor:   Bayer
Recruiting - verified August 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Germany)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Phenprocoumon
Sponsor:   Bayer
Recruiting - verified August 2015

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxoban (Xarelto, Bay59-7939);   Drug: Acenocoumarol
Sponsor:   Bayer
Recruiting - verified August 2015

GLORIA-AF Registry Program (Phase II/III)

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified August 2015

Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

Condition:   Anticoagulation
Intervention:   Drug: Apixaban
Sponsors:   Bristol-Myers Squibb;   Pfizer
Active, not recruiting - verified July 2015

GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified August 2015

GLORIA-AF Registry Program - Second and Third Phases

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified August 2015

Whole-leg Ultrasound in Pregnant Patients

Condition:   Deep Vein Thrombosis
Intervention:   Other: Whole-leg compression ultrasound
Sponsor:   Intermountain Health Care, Inc.
Recruiting - verified August 2015

Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)

Conditions:   Anti-coagulation Therapy;   DVT;   Pulmonary Embolism;   Joint Surgery Multiple;   Atrial Fibrillation;   Prosthetic Replacement of Mitral Valve
Intervention:   Device: Warfarin GenoSTAT Test
Sponsor:   Iverson Genetic Diagnostics, Inc.
Suspended - verified August 2015

Get CardioSmart

You're Invited